Related content

Implications of Genetic Testing in the Management of Colorectal Cancer

By Stoehlmacher J.   Lenz H-J.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 73-88

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike   Tran Agnès   Rey Elisabeth   Pons Gérard   Tréluyer Jean-Marc  

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Emerging VEGF-receptor inhibitors for colorectal cancer

By Martinelli Erika   Troiani Teresa   Morgillo Floriana   Orditura Michele   De Vita Fernando   Belli Giulio   Ciardiello Fortunato  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 25-37

Informa Healthcare

Access to resources Recommend Favorite

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

By Stremitzer Stefan   Zhang Wu   Yang Dongyun   Ning Yan   Stintzing Sebastian   Sebio Ana   Sunakawa Yu   Yamauchi Shinichi   Matsusaka Satoshi   El-Khoueiry Rita   Stift Judith   Wrba Friedrich   Gruenberger Thomas   Lenz Heinz-Josef  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1898-1905

Blackwell Publishing

Access to resources Recommend Favorite

Mobile Genetic Element Activation and Genotoxic Cancer Therapy: Potential Clinical Implications

By Hagan C.R.   Rudin C.M.  

American Journal of PharmacoGenomics, Vol. 2, Iss. 1, 2002-01 ,pp. : 25-35

Adis International

Access to resources Recommend Favorite